Authors:
SZANTO I
SOEDIRMAN JR
SZANTHO A
JASSEM J
SAJDAK S
TALERCZYK M
KORALEWSKI P
AZIZ Z
PLUZANSKA A
Citation: I. Szanto et al., MITOMYCIN-C, IFOSFAMIDE, CISPLATIN (MIC) IN PATIENTS WITH ADVANCED ORRECURRENT CERVICAL-CANCER, Annals of oncology, 9, 1998, pp. 340-340
Authors:
JASSEM J
ZATLOUKAL P
KANITZ E
MAGYAR P
KRZAKOWSKI M
PAWLICKI M
PETRUZELKA L
CHOVAN L
PESEK M
KREJCY K
Citation: J. Jassem et al., GEMCITABINE IN LOCALLY ADVANCED AND METASTATIC NONSMALL CELL LUNG-CANCER (NSCLC) - THE CENTRAL-EUROPEAN PHASE-II STUDY, Annals of oncology, 9, 1998, pp. 433-433
Authors:
KLIJN JGM
BEEX L
MAURIAC L
VANZIJL J
VEYRET C
WILDIERS J
JASSEM J
BURGHOUTS J
PICCART M
MIGNOLET F
DUCHATEAU L
Citation: Jgm. Klijn et al., COMBINED TREATMENT WITH THE LHRH-AGONIST BUSERELIN (LHRH-A) AND TAMOXIFEN (TAM) VS SINGLE TREATMENT WITH EACH DRUG ALONE IN PREMENOPAUSAL METASTATIC BREAST-CANCER - FINAL RESULTS OF EORTC-STUDY-10881, Annals of oncology, 9, 1998, pp. 540-540
Authors:
JERECZEKFOSSA B
JASSEM J
NOWAK R
BADZIO A
Citation: B. Jereczekfossa et al., LATE COMPLICATIONS AFTER POSTOPERATIVE RADIOTHERAPY IN ENDOMETRIAL CANCER - ANALYSIS OF 317 CONSECUTIVE CASES WITH APPLICATION OF LINEAR-QUADRATIC MODEL, International journal of radiation oncology, biology, physics, 41(2), 1998, pp. 329-338
Authors:
JERECZEKFOSSA B
JASSEM J
KARNICKAMLODKOWSKA H
BADZIO A
MOSANTKOWIAK R
KRAWCZYK K
KOWAL E
PILARSKAMACHOWICZ A
RADZIKOWSKA E
MALAK K
Citation: B. Jereczekfossa et al., DOES CHEMOTHERAPY-INDUCED LEUKOPENIA PREDICT A RESPONSE IN SMALL-CELLLUNG-CANCER, Journal of cancer research and clinical oncology, 124(2), 1998, pp. 106-112
Authors:
BONTENBAL M
ANDERSSON M
WILDIERS J
COCCONI G
JASSEM J
PARIDAENS R
ROTMENSZ N
SYLVESTER R
MOURIDSEN HT
KLIJN JGM
VANOOSTEROM AT
Citation: M. Bontenbal et al., DOXORUBICIN VS EPIRUBICIN, REPORT OF A 2ND-LINE RANDOMIZED PHASE-II PHASE-III STUDY IN ADVANCED BREAST-CANCER/, British Journal of Cancer, 77(12), 1998, pp. 2257-2263
Authors:
JERECZEKFOSSA B
JASSEM J
BADZIO A
SERKIES K
KOBIERSKA A
Citation: B. Jereczekfossa et al., FACTORS DETERMINING LATE COMPLICATIONS FOLLOWING POSTOPERATIVE RADIOTHERAPY IN ENDOMETRIAL CARCINOMA, European journal of cancer, 33, 1997, pp. 430-430
Authors:
PAWLICKI M
JASSEM J
BOSZE P
LOTAN C
KURTEVA GP
SIDDIQUI M
KOSMIDIS PA
RIGATOS GA
KANSU E
DURKOVIC P
AZIZ Z
ALIDRISSI H
ROTH A
COZMA G
Citation: M. Pawlicki et al., A MULTICENTER STUDY OF RECOMBINANT-HUMAN-ERYTHROPOIETIN (EPOETIN-ALPHA) IN THE MANAGEMENT OF ANEMIA IN CANCER-PATIENTS RECEIVING CHEMOTHERAPY, Anti-cancer drugs, 8(10), 1997, pp. 949-957
Authors:
DEANTA JM
JASSEM E
ROSELL R
MARTINEZROCA M
JASSEM J
MARTINEZLOPEZ E
MONZO M
SANCHEZHERNANDEZ JJ
MORENO I
SANCHEZCESPEDES M
Citation: Jm. Deanta et al., TP53 MUTATIONAL PATTERN IN SPANISH AND POLISH NONSMALL CELL LUNG-CANCER PATIENTS - NULL MUTATIONS ARE ASSOCIATED WITH POOR-PROGNOSIS, Oncogene, 15(24), 1997, pp. 2951-2958
Authors:
SENKUSKONEFKA E
KOBIERSKA A
JASSEM J
BADZIO A
Citation: E. Senkuskonefka et al., PATIENT-RELATED FACTORS DETERMINING GEOMETRY OF INTRACAVITARY APPLICATORS AND PELVIC DOSE DISTRIBUTION DURING CERVICAL-CANCER BRACHYTHERAPY, International journal of radiation oncology, biology, physics, 37(3), 1997, pp. 531-536
Citation: B. Jereczek et al., SARCOMA OF THE UTERUS - A CLINICAL-STUDY OF 42 PATIENTS, Archives of gynecology and obstetrics, 258(4), 1996, pp. 171-180
Citation: H. Bartelink et J. Jassem, POSTOPERATIVE RADIOTHERAPY IN NON-SMALL-CELL LUNG-CANCER - MORE QUESTIONS THAN ANSWERS, British Journal of Cancer, 74(4), 1996, pp. 495-495
Citation: B. Jereczek et al., PRIMARY-CANCER OF THE FALLOPIAN-TUBE - REPORT OF 26 PATIENTS, Acta obstetricia et gynecologica Scandinavica, 75(3), 1996, pp. 281-286
Citation: J. Jassem et H. Bartelink, CHEMOTHERAPY IN LOCALLY ADVANCED HEAD AND NECK-CANCER - A CRITICAL REAPPRAISAL, Cancer treatment reviews, 21(5), 1995, pp. 447-462
Authors:
JASSEM J
KARNICKAMLODKOWSKA H
JASSEM E
SLUPEK A
ZYCH J
WIATR E
MALAK S
MOSANTKOWIAK R
SZYMACZEKMEYER L
PILARSKAMACHOWICZ A
JERECZEK B
Citation: J. Jassem et al., COMBINATION CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, EPIRUBICIN AND ETOPOSIDE IN SMALL-CELL LUNG-CANCER, Lung cancer, 11(3-4), 1994, pp. 283-291
Authors:
GOLDSTRAW P
ROCMANS P
BALL D
BARTHELEMY N
BONNER J
CARETTE M
CHOI N
EMAMI B
GRUNENWALD D
HAZUKA M
IHDE D
JASSEM J
KHO G
LECHEVALIEIR T
MONTEAU M
STORME G
WAGENAAR S
Citation: P. Goldstraw et al., PRETREATMENT MINIMAL STAGING FOR NONSMALL CELL LUNG-CANCER - AN UPDATED CONSENSUS REPORT, Lung cancer, 11, 1994, pp. 1-4
Authors:
MIRIMANOFF RO
RUBIN P
COX JD
GANDARA D
GRUNENWALD D
HAZUKA M
JASSEM J
KOMAKI R
MATTSON K
MCDONALD S
MORNEX F
PALAZZI M
PAVY JJ
REBOUL F
SHAW E
STORME G
STOUT R
SUTEDJA T
TROVO MD
VOKES E
ZANELLI G
Citation: Ro. Mirimanoff et al., CONCOMITANT AND ALTERNATING RADIATION-THERAPY (RT) AND CHEMOTHERAPY (CT) FOR INOPERABLE, MO, NONSMALL CELL LUNG CANCERS (NSCLC) - A CONSENSUS REPORT, Lung cancer, 11, 1994, pp. 5-8
Authors:
JASSEM J
KARNICKAMLODKOWSKA H
VANPOTTELSBERGHE C
VANGLABBEKE M
NOSEDA MA
ARDIZZONI A
GOZZELINO F
PLANTING A
VANZANDWIJK N
Citation: J. Jassem et al., PHASE-II STUDY OF VINORELBINE (NAVELBINE) IN PREVIOUSLY TREATED SMALL-CELL LUNG-CANCER PATIENTS, European journal of cancer, 29A(12), 1993, pp. 1720-1722